AB Sciex to Drive Innovation in Separations Science with Combination of Eksigent Chromatography with Capillary Electrophoresis from Beckman Coulter Life Sciences

We are combining our chromatography business with the capillary electrophoresis (CE) business from Beckman Coulter Life Sciences.

2013-07-10

AB Sciex Pte. Ltd., a global leader in analytical technologies, today announced the combination of its chromatography business with the capillary electrophoresis (CE) business from Beckman Coulter Life Sciences, an innovator in life science research, to advance separations science.  This move brings together Beckman Coulter's expertise in microscale separation with the expertise in microfluidics of the Eksigent chromatography team of AB Sciex. 

This combination includes the transition of personnel as well as CE technologies and resources from Beckman Coulter Life Sciences to AB Sciex ‒ two leading life science companies that are both owned by Danaher Corporation, a leader in science and technology. This new alignment will enable better serving of customers while addressing analytical challenges with powerful scientific strategies that take advantage of complementary technologies.

"We are bringing together the best in CE with the best in nano LC and micro LC as a unified team to broaden the range of solutions available to our customers," said Rainer Blair, President of AB Sciex.  "By integrating the Beckman Coulter CE team into the Sciex separations business, we will be able to take CE and our chromatography solutions to a whole new level. We are committed to investing in our separations business for long-term success."

The Eksigent LC team of the Sciex separations business and the CE team of Beckman Coulter, a leader in benchtop capillary electrophoresis, will work together going forward to develop breakthrough, integrated applications that provide fast and efficient separations of drugs, drug metabolites, organic acids, amino acids, low molecular weight amines, peptides, nucleic acids and nucleosides.

The new alignment within the Sciex separations business will also unlock greater potential to extend technology leadership, synergies and market presence.  This will contribute to the advancement of biologics, clinical research and academic research for biological applications.

Among the synergies is the combination of CE technology and mass spectrometry (MS) technology.  CE-MS allows researchers to expand the range of analytes detected while improving overall assay sensitivity. The selectivity of CE in front-end separation further enables the characterization of intact proteins, their isoforms, cleaved fragments and complexes. CE-MS provides information that is complementary to nano LC for proteomics research.

By the end of Q3, the Sciex separations business will manage both the standalone Beckman Coulter CE products and the integrated CE-MS technology.  The CE products will continue to be branded 'Beckman Coulter.' The separations business will also continue to manage all chromatography products, including Eksigent nano LC and micro LC systems, chips, software and columns.

About Beckman Coulter Life Sciences
Beckman Coulter Life Sciences is dedicated to improving the health of people around the world. The company's global leadership and world-class service and support delivers sophisticated instrument systems, reagents and services to life science researchers in academic and commercial laboratories, enabling new discoveries in biology-based research and development. A leader in centrifugation and flow cytometry, Beckman Coulter has long been an innovator in capillary electrophoresis, particle characterization and laboratory automation, and its products are used at the forefront of important areas of investigation, including genomics and proteomics.

About AB Sciex
AB Sciex helps to improve the world we live in by enabling scientists and laboratory analysts to push the limits in their field and address the complex analytical challenges they face.  The company's global leadership and world-class service and support in the mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research.  With 40 years of proven innovation, AB Sciex excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. Follow AB SCIEX on Twitter @ABSCIEX and on Facebook and LinkedIn.

© 2013. AB Sciex. Unless otherwise noted in our product literature, AB Sciex Products Are For Research Use Only. Not for use in Diagnostics Procedures. For more information, refer to sciex.com.cn/products. The trademarks mentioned herein are the property of AB Sciex Pte. Ltd. or their respective owners. AB SCIEXTM is being used under license.

Beckman Coulter and the stylized logo are trademarks of Beckman Coulter, Inc. and are registered with the USPTO.

AB Sciex Media Contact

Anthony Petrucci

Public Relations
Beckman Coulter Life Sciences Media Contact

Hillary Hunter

Public Relations

关于 SCIEX

SCIEX 致力于用创新和精准的科学理念,整合可靠解决方案,促进人类科学认知,改善和提高人们的健康、安全。我们在质谱技术领域拥有50年的创新经验。从1981年成功推出台商业化的三重四极质谱系统开始,我们一直致力于开发突破性的技术和解决方案,从而影响和推进可以改善生活的科学研究和成果。

今天,SCIEX作为全球生命科学和技术创新者的丹纳赫集团(Danaher)一员,我们将继续在质谱和毛细管电泳技术领域开发稳健的解决方案。 我们可以帮助客户监测环境危害因子并做出迅速响应;更好的理解疾病和疾病标志物,改善疾病的临床治疗,助力相关药物研发上市;保证食物更健康和更安全。

这就是世界各地的科学家们愿意选择SCIEX产品的原因,我们帮助您获得可靠的结果,以便您做出更好的关键决策,从而改善人们的生活。

获取更多信息, 请访问 sciex.com.cn .

联系我们: WeChatLinkedIn, 和 YOUKU.

全国咨询电话: 800-820-3488, 400-821-3897.

人类健康的改善依赖于精确科学的力量。